Latest Breaking News On - Ability pharmaceuticals - Page 1 : comparemela.com

AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812

AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients. 

AbilityPharma Announces ? 7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer

AbilityPharma Raises €7M in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Pancreatic Cancer Treatment Market 2032: Epidemiology Data, Therapies, FDA, EMA and PDMA Approvals, Companies and Forecast by DelveInsight

"Pancreatic Cancer Treatment Market"(Albany, USA) DelveInsight's "Pancreatic Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Pancreatic Cancer, historical and

DelveInsight Business Research, LLP: Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain

The prevalence of pancreatic cancer has been rising since the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cancer, the robust pipeline